Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Stallergenes Greer's share price for the quarter that ended in Dec. 2018 was $0. Stallergenes Greer's Shares Outstanding (EOP) for the quarter that ended in Dec. 2018 was 19.74 Mil. Therefore, Stallergenes Greer's market cap for the quarter that ended in Dec. 2018 was $0.00 Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Stallergenes Greer's Enterprise Value for Today is $811.38 Mil.
Stallergenes Greer Market Cap Historical Data
The historical data trend for Stallergenes Greer's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Stallergenes Greer's Market Cap
For the Biotechnology subindustry, Stallergenes Greer's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stallergenes Greer's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Stallergenes Greer's Market Cap distribution charts can be found below:
* The bar in red indicates where Stallergenes Greer's Market Cap falls into.
Stallergenes Greer Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Stallergenes Greer's Market Cap for the fiscal year that ended in Dec. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stallergenes Greer (GREY:STLLF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Stallergenes Greer Market Cap Related Terms
Thank you for viewing the detailed overview of Stallergenes Greer's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Stallergenes Greer (Stallergenes Greer) Business Description
Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STLLF has been successfully added to your 